Stephane Borentain

The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder

Ella Daly, Ibrahim Turkoz, Giacomo Salvadore et al. · Depression and Anxiety · 2021 · 42 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Patient-reported outcomes in major depressive disorder with suicidal ideation: a real-world data analysis using PatientsLikeMe platform

Stephane Borentain, Abigail I. Nash, Rachna Dayal et al. · BMC Psychiatry · 2020 · 37 citations · Full text

Medicine, Psychiatry, Psychology +12

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine

Stephane Borentain, Jagadish Gogate, David Williamson et al. · International Journal of Methods in Psychiatric Research · 2022 · 29 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression

Joachim Morrens, Maju Mathews, Vanina Popova et al. · Neuropsychiatric Disease and Treatment · 2022 · 23 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study

Meredith Castro, Samuel T. Wilkinson, Rayan K. Al Jurdi et al. · CNS Drugs · 2023 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17